Top Markets
#1 AntFun AntFun +102.30%
#2 Mubarak Mubarak +45.78%
#3 SODAX SODAX +29.65%
#4 Nillion Nillion +28.33%
#5 MarsCoin MarsCoin +21.80%
#6 EXOD EXOD +21.04%
#7 CZ'S Dog CZ'S Dog +20.63%
#8 Bitcoin Cash Bitcoin Cash +20.18%
#9 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +19.65%
#10 PumpMeme PumpMeme +17.41%
Coin of the day
AntFun AntFun
Settings
Language
ENGLISH
Currency
USD
Theme
AbbVie Inc. AbbVie Inc.

AbbVie Inc.

ABBV
Rank in Stocks #27
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery,... AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Virology: MAVYRET offers a treatment option for individuals with chronic HCV genotype 1-6 infection. Gastroenterology and Endocrinology: The company supplies CREON, an enzyme replacement therapy for exocrine pancreatic insufficiency, and Synthroid, used to manage hypothyroidism. Linzess/Constella helps treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. Women's Health and Urology: Lupron serves as a palliative treatment for conditions like advanced prostate cancer, endometriosis, central precocious puberty, and anemia caused by uterine fibroids. ORILISSA, a nonpeptide small molecule GnRH antagonist, is designed for women experiencing moderate to severe endometriosis pain. Neurology: AbbVie offers Duopa and Duodopa, a levodopa-carbidopa intestinal gel for Parkinson's disease, and Ubrelvy to treat migraines (with or without aura) in adults. The therapeutic formulation of Botox is also part of its offerings. Ophthalmology: Its eye care segment features Lumigan/Ganfort (a bimatoprost ophthalmic solution) and Alphagan/Combigan (an alpha-adrenergic receptor agonist), both aimed at reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension. Restasis, a calcineurin inhibitor immunosuppressant, is provided to enhance tear production, alongside other specialized eye care products. AbbVie Inc. also engages in research collaborations, including a partnership with Dragonfly Therapeutics, Inc. The company was founded in 2012 and operates from its headquarters in North Chicago, Illinois.
Share Price
$263.38
Market Cap
$465.34B
Change (1 day)
-0.63%
Change (1 year)
18.33%
Country
US
Trade AbbVie Inc. (ABBV)

Category

Healthcare
Stock price history for AbbVie Inc. (ABBV)
Highest end of day price: $259.51 on 2026-09-01

Lowest end of day price: $34.40 on 2012-12-01
Stock price history of AbbVie Inc. from 2012 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 1.19%
2025 28.51%
2024 16.40%
2023 -7.17%
2022 27.60%
2021 21.67%
2020 19.07%
2019 0.53%
2018 -9.28%
2017 57.12%
2016 7.67%
2015 -15.03%
2014 29.37%
2013 51.26%
2012 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.16K 53.70%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $266.32 52.87%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $483.55 35.09%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $150.51 87.20%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
 $150.37 21.20%
CH